BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9154180)

  • 1. Clinical development plan: sulindac sulfone.
    J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development plan: 13-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical development plan: vitamin A.
    J Cell Biochem Suppl; 1996; 26():269-307. PubMed ID: 9154183
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical development plan: 1,4-penylenebis(methylene)selenocyanate.
    J Cell Biochem Suppl; 1996; 26():219-26. PubMed ID: 9154179
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical development plan: dehydroepiandrosterone (DHEA).
    J Cell Biochem Suppl; 1996; 26():86-99. PubMed ID: 9154170
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development plan: (+)-vorozole.
    J Cell Biochem Suppl; 1996; 26():308-15. PubMed ID: 9154184
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical development plan: l-Selenomethionine.
    J Cell Biochem Suppl; 1996; 26():202-18. PubMed ID: 9154178
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development plan: curcumin.
    J Cell Biochem Suppl; 1996; 26():72-85. PubMed ID: 9154169
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical development plan: genistein.
    J Cell Biochem Suppl; 1996; 26():114-26. PubMed ID: 9154172
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical development plan: phenethyl isothiocyanate.
    J Cell Biochem Suppl; 1996; 26():149-57. PubMed ID: 9154175
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
    J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical development plan: indole-3-carbinol.
    J Cell Biochem Suppl; 1996; 26():127-36. PubMed ID: 9154173
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical development plan: folic acid.
    J Cell Biochem Suppl; 1996; 26():100-13. PubMed ID: 9154171
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical development plan: sulindac.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():240-51. PubMed ID: 7616747
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical development plan: ursodiol.
    J Cell Biochem Suppl; 1996; 26():258-68. PubMed ID: 9154182
    [No Abstract]   [Full Text] [Related]  

  • 16. Exisulind shows positive results in the prevention of precancerous colon polyps.
    Oncology (Williston Park); 2000 May; 14(5):772-3. PubMed ID: 10853464
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical development plan: 9-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():158-67. PubMed ID: 9154176
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical development plan: l-perillyl alcohol.
    J Cell Biochem Suppl; 1996; 26():137-48. PubMed ID: 9154174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development plan: oltipraz.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():205-18. PubMed ID: 7616744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.